(Q34574505)

3 August 2017

1 reference

title

Antibodies against gangliosides: a link between preceding infection and immunopathogenesis of Guillain-Barré syndrome (English)

1 reference

3 August 2017

main subject

Guillain–Barré syndrome

0 references

1 reference

Beatrix Schwerer

1

1 reference

3 August 2017

publication date

1 March 2002

1 reference

3 August 2017

published in

Microbes and Infection

1 reference

3 August 2017

volume

4

1 reference

3 August 2017

issue

3

1 reference

3 August 2017

page(s)

373-384

1 reference

3 August 2017

cites work

Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901550-2

7 January 2021

Human autoimmune neuropathies

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901550-2

7 January 2021

Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901550-2

7 January 2021

Guillain-Barré syndrome, CIDP and other chronic immune-mediated neuropathies

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901550-2

7 January 2021

Pathogenesis of Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901550-2

7 January 2021

Immune attack on the schwann cell surface in acute inflammatory demyelinating polyneuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901550-2

7 January 2021

Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901550-2

7 January 2021

Acute motor axonal neuropathy: An antibody-mediated attack on axolemma

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901550-2

7 January 2021

Pathology of the motor-sensory axonal Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901550-2

7 January 2021

The immunopathogenesis of Miller Fisher syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901550-2

7 January 2021

Ganglioside composition of the human cranial nerves, with special reference to pathophysiology of Miller Fisher syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901550-2

7 January 2021

Role of infection in Guillain-Barré syndrome: laboratory confirmation of herpesviruses in 41 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901550-2

7 January 2021

Mycoplasma antibody in Guillain-Barré syndrome and other neurological disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901550-2

7 January 2021

Campylobacter jejuni infection and Guillain-Barré syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901550-2

7 January 2021

Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901550-2

7 January 2021

Antibodies to gangliosides and galactocerebroside in patients with Guillain-Barré syndrome with preceding Campylobacter jejuni and other identified infections

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901550-2

7 January 2021

Cytomegalovirus infection and Guillain-Barré syndrome: the clinical, electrophysiologic, and prognostic features. Dutch Guillain-Barré Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901550-2

7 January 2021

Antiganglioside antibodies in Guillain-Barré syndrome after a recent cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901550-2

7 January 2021

Anti-ganglioside GM1 antibodies in Guillain-Barré syndrome and their relationship to Campylobacter jejuni infection

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901550-2

7 January 2021

Association of Campylobacter jejuni serotype with antiganglioside antibody in Guillain-Barré syndrome and Fisher's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901550-2

7 January 2021

Campylobacter jejuni lipopolysaccharides in Guillain-Barré syndrome: molecular mimicry and host susceptibility

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901550-2

7 January 2021

Miller-Fisher syndrome associated with Campylobacter jejuni bearing lipopolysaccharide molecules that mimic human ganglioside GD3.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901550-2

7 January 2021

A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901550-2

7 January 2021

Chemical structures of the core regions of Campylobacter jejuni serotypes O:1, O:4, O:23, and O:36 lipopolysaccharides

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901550-2

7 January 2021

Chemical structure of the core region of Campylobacter jejuni serotype O:2 lipopolysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901550-2

7 January 2021

Lipopolysaccharides of Campylobacter jejuni serotype O:19: structures of core oligosaccharide regions from the serostrain and two bacterial isolates from patients with the Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901550-2

7 January 2021

Humoral immune response against Campylobacter jejuni lipopolysaccharides in Guillain-Barré and Miller Fisher syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901550-2

7 January 2021

Serum antibodies against gangliosides and Campylobacter jejuni lipopolysaccharides in Miller Fisher syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901550-2

7 January 2021

Monoclonal antibodies raised against Guillain-Barré syndrome-associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparations.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901550-2

7 January 2021

Guillain-Barré syndrome- and Miller Fisher syndrome-associated Campylobacter jejuni lipopolysaccharides induce anti-GM1 and anti-GQ1b Antibodies in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901550-2

7 January 2021

HLA-class II alleles in Guillain-Barré syndrome and Miller Fisher syndrome and their association with preceding Campylobacter jejuni infection

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901550-2

7 January 2021

HLA and T-cell receptor gene polymorphisms in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901550-2

7 January 2021

Gangliosides and bacterial toxins in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901550-2

7 January 2021

Antibody to GalNAc-GD1a and GalNAc-GM1b in Guillain-Barré syndrome subsequent to Campylobacter jejuni enteritis

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901550-2

7 January 2021

Close association of Guillain-Barré syndrome with antibodies to minor monosialogangliosides GM1b and GM1 alpha

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901550-2

7 January 2021

Antibodies to GT1a ganglioside in patients with Guillain-Barré syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901550-2

7 January 2021

Acute axonal Guillain-Barré syndrome with IgG antibodies against motor axons following parenteral gangliosides

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901550-2

7 January 2021

Ganglioside-induced antiganglioside antibodies from a neuropathy patient cross-react with lipopolysaccharides of Campylobacter jejuni associated with Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901550-2

7 January 2021

N-glycolylneuraminic acid-containing GM1 is a new molecule for serum antibody in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901550-2

7 January 2021

Rapidly progressive, predominantly motor Guillain-Barré syndrome with anti-GalNAc-GD1a antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901550-2

7 January 2021

Guillain-Barré syndrome with antibody to a ganglioside, N-acetylgalactosaminyl GD1a

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901550-2

7 January 2021

Clinical features and response to treatment in Guillain-Barré syndrome associated with antibodies to GM1b ganglioside

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901550-2

7 January 2021

Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901550-2

7 January 2021

Acute oropharyngeal palsy is associated with antibodies to GQ1b and GT1a gangliosides

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901550-2

7 January 2021

Monospecific anti-GD1b IgG is required to induce rabbit ataxic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901550-2

7 January 2021

Mice lacking complex gangliosides develop Wallerian degeneration and myelination defects

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901550-2

7 January 2021

High-affinity anti-ganglioside IgG antibodies raised in complex ganglioside knockout mice: reexamination of GD1a immunolocalization.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901550-2

7 January 2021

Autoantibodies associated with peripheral neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901550-2

7 January 2021

The distribution of ganglioside-like moieties in peripheral nerves

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901550-2

7 January 2021

Mapping immunoreactive epitopes in the human peripheral nervous system using human monoclonal anti-GM1 ganglioside antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901550-2

7 January 2021

Facts and fallacies on anti-GM1 antibodies: physiology of motor neuropathies

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901550-2

7 January 2021

Mechanisms of action of anti-GM1 and anti-GQ1b ganglioside antibodies in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901550-2

7 January 2021

Human IgM paraproteins demonstrate shared reactivity between Campylobacter jejuni lipopolysaccharides and human peripheral nerve disialylated gangliosides

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901550-2

7 January 2021

Antibodies against GM1 ganglioside affect K+ and Na+ currents in isolated rat myelinated nerve fibers

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901550-2

7 January 2021

Anti-ganglioside antibodies can bind peripheral nerve nodes of Ranvier and activate the complement cascade without inducing acute conduction block in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901550-2

7 January 2021

Failure of anti-GM1 IgG or IgM to induce conduction block following intraneural transfer

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901550-2

7 January 2021

The physiological effect of anti-GM1 antibodies on saltatory conduction and transmembrane currents in single motor axons.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901550-2

7 January 2021

Miller Fisher anti-GQ1b antibodies: alpha-latrotoxin-like effects on motor end plates

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901550-2

7 January 2021

Anti-GQ1b ganglioside antibodies mediate complement-dependent destruction of the motor nerve terminal

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901550-2

7 January 2021

Combined pre- and postsynaptic action of IgG antibodies in Miller Fisher syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901550-2

7 January 2021

Anti-GM1 ganglioside IgM-antibodies present in human plasma: affinity and biological activity changes in a patient with neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901550-2

7 January 2021

IgG anti-GM1 antibodies from patients with acute motor neuropathy are predominantly of the IgG1 and IgG3 subclasses

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901550-2

7 January 2021

Subclass of IgG antibody to GM1 epitope-bearing lipopolysaccharide of Campylobacter jejuni in patients with Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901550-2

7 January 2021

Affinity of anti-GM1 antibodies in Guillain-Barré syndrome patients

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901550-2

7 January 2021

Immunoglobulin subclass distribution and binding characteristics of anti-GQ1b antibodies in Miller Fisher syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901550-2

7 January 2021

Distinct immunoglobulin class and immunoglobulin G subclass patterns against ganglioside GQ1b in Miller Fisher syndrome following different types of infection

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901550-2

7 January 2021

CD1-restricted T cell recognition of microbial lipoglycan antigens

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901550-2

7 January 2021

Self glycolipids as T-cell autoantigens

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901550-2

7 January 2021

A somatically mutated human antiganglioside IgM antibody that induces experimental neuropathy in mice is encoded by the variable region heavy chain gene, V1-18.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901550-2

7 January 2021

Close association of IgA anti-ganglioside antibodies with antecedent Campylobacter jejuni infection in Guillain-Barré and Fisher's syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901550-2

7 January 2021

Subclass distribution and the secretory component of serum IgA anti-ganglioside antibodies in Guillain-Barré syndrome after Campylobacter jejuni enteritis

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901550-2

7 January 2021

Haemophilus influenzae infection and Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901550-2

7 January 2021

10.1016/S1286-4579(02)01550-2

Identifiers

DOI

1 reference

3 August 2017

1 reference